Multiple Myeloma

Most read articles by the same author(s)

• Sergei Vyacheslavovich Semochkin, Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 17 No. 2 (2024)
• Sergei Vyacheslavovich Semochkin, Functional Cure as a New Concept of Therapy for Multiple Myeloma , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 18 No. 2 (2025)
• Sergei Vyacheslavovich Semochkin, CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022 , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 16 No. 1 (2023)
• Sergei Vyacheslavovich Semochkin, E.I. Zhelnova, V.I. Kazey, A.V. Cherkasova, A.G. Nikiforova, N.F. Frolova, E.A. Baryakh, K.V. Yatskov, E.A. Karimova, O.N. Kotenko, E.N. Misyurina, The Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination as Induction Therapy in Patients with Multiple Myeloma Complicated by the End-Stage Renal Disease , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 17 No. 4 (2024)
• Sergei Vyacheslavovich Semochkin, Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 16 No. 3 (2023)
• Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov, Practical Aspects of the Use of Carfilzomib in Multiple Myeloma , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 12 No. 1 (2019)
• Sergei Vyacheslavovich Semochkin, Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma , Clinical Oncohematology. Basic Research and Clinical Practice: Vol. 8 No. 4 (2015)